US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents
Patent application publication
TW202113082A - Antisense oligonucleotides targeting atxn3 - Google Patents
US20170175113A1 - Methods for modulating ataxin 2 expression - Google Patents
Compounds and methods for reducing atxn3 expression - Eureka
US20170175113A1 - Methods for modulating ataxin 2 expression - Google Patents
US20170175113A1 - Methods for modulating ataxin 2 expression - Google Patents
WO2020006018A1 - Substituted naphthyridinone compounds useful as t cell activators - Google Patents
US20220195431A1 - Compounds and methods for reducing atxn3 expression - Google Patents
ATXN3 Gene - GeneCards, ATX3 Protein
US10881730B2 - Immunomodulatory therapeutic MRNA compositions encoding activating oncogene mutation peptides - Google Patents
US7612114B2 - Selective estrogen receptor modulator - Google Patents
Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein - ScienceDirect
US20220195431A1 - Compounds and methods for reducing atxn3 expression - Google Patents
US7612114B2 - Selective estrogen receptor modulator - Google Patents
US20200385727A1 - Antisense oligonucleotides targeting atxn3 - Google Patents
US10808039B2 - Monomethylvaline compounds capable of conjugation to ligands - Google Patents